Katie Wilkes/LinkedIn
Nov 16, 2025, 20:27
Katie Wilkes Shares Her Inspiring Experience with Hope for Hemophilia
Katie Wilkes, Director of Sales, Marketing, and Logistics at George King Bio-Medical, reposted from George King Bio-Medical on LinkedIn:
”What a great conference this was last week.
I am so happy I was there to experience what the Hope for Hemophilia organization is all about,
Until next year…”
Quoting George King Bio-Medical‘s post:
”George King Bio-Medical, Inc. had a wonderful time at the 2025 HOPE Conference in Orlando!
We’re grateful to be part of such a passionate and supportive community dedicated to making a difference for those affected by bleeding disorders.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 15:42Marc Carrier: Important New Data From the API-CAT Trial on Recurrent VTE During Extended Apixaban Therapy
-
Jul 13, 2026, 15:23Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026
-
Jul 13, 2026, 15:15Alfonso J. Tafur: Insights on Periprocedural DOAC Management in Atrial Fibrillation at ISTH 2026
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026